Loading data for GOSS — first visit, this takes a few seconds.
Gossamer Bio Inc. (GOSS)
: GOSS
· リアルタイム株価 · USD
n/a
n/a (n/a)
終値時点： Invalid Date
0.16
+1.60%
時間外: 5:13 PM
Gossamer Bio Inc. (GOSS) Stock Price, Analysis & Data
データがありません
GOSSについて
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It ha...
セクター Healthcare
IPO日 Feb 8, 2019
従業員数 161
上場取引所 NasdaqGS
ティッカー GOSS
ウェブサイト https://www.gossamerbio.com